Yi Luo

Dr. Yi Luo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YLYi Luo
Yi Luo
AHAiling Hu
Ailing Hu
JLJingya Lu
Jingya Lu
WYWenshu Yuan
Wenshu Yuan
YTYu Tan
Yu Tan
HKHiroyuki Kobayashi
Hiroyuki Kobayashi
Boiogito (BOT), a traditional Kampo herbal medicine, has been reported to exhibit anti-inflammatory and anti-obesity properties. However, its potential role in protecting adipocyte function under inflammatory conditions at different stages of adipocyte development remains unclear. This study investigated the effects of BOT on adipogenesis and tumor necrosis factor-α (TNF-α)-induced inflammatory responses in differentiating and mature 3T3-L1 adipocytes. In this study, 3T3-L1 preadipocytes were induced to differentiate and exposed to TNF-α in the presence or absence of BOT during differentiation or after full adipocyte maturation. Lipid accumulation was assessed by Oil Red O staining, while adipokine secretion and inflammatory cytokine production were evaluated by ELISA. The expression of adipogenic markers and inflammatory signaling molecules was analyzed using quantitative PCR and Western blotting. TNF-α significantly inhibited the expression of adipogenesis-related factors at the transcriptional level in adipocytes, reduced lipid accumulation and adiponectin expression, and enhanced inflammatory cytokine production. BOT treatment dose-dependently attenuated these effects, restoring adipogenic capacity and suppressing inflammatory responses in both differentiating and mature adipocytes. Mechanistically, BOT reduced TNF-α-induced activation of the NF-κB pathway, as evidenced by decreased phosphorylation of NF-κB p65 and IκB. These findings demonstrate that BOT preserves adipocyte function and mitigates inflammation-associated adipocyte dysfunction throughout adipocyte development. The protective effects of BOT may contribute to the regulation of obesity-associated metabolic inflammation, partly through modulation of NF-κB signaling.

Verified
Journal Article
Open access
PDF file
YLYi Luo
Yi Luo
AHAiling Hu
Ailing Hu
JLJingya Lu
Jingya Lu
TYTakuji Yamaguchi
Takuji Yamaguchi
YIYasushi Ikarashi
Yasushi Ikarashi
HKHiroyuki Kobayashi
Hiroyuki Kobayashi
Chronic inflammation and oxidative stress in obese adipose tissue are pivotal drivers of insulin resistance and metabolic dysfunction. We previously demonstrated that the Kampo formula Boiogito (BOT) ameliorates impaired adipocyte differentiation and inflammation by inhibiting the nuclear factor kappa B (NF-κB) pathway in a tumor necrosis factor–alpha (TNF-α)-induced model. However, the specific effects of BOT on oxidative stress and glucose uptake remain to be elucidated. This study aimed to elucidate whether BOT could ameliorate hydrogen peroxide (H2O2)-induced oxidative stress, inflammation, and cellular dysfunction in 3T3-L1 adipocytes, thereby restoring impaired glucose uptake capacity. Differentiating and mature 3T3-L1 adipocytes were treated with 200 µM H2O2 alone or in combination with BOT (0.25 and 0.5 mg/mL). Oxidative stress markers (reactive oxygen species [ROS] and superoxide dismutase [SOD]), inflammatory cytokines (interleukin-6 [IL-6], monocyte chemoattractant protein-1 [MCP-1], and TNF-α), differentiation/functional markers (peroxisome proliferator-activated receptor gamma [Pparγ] and CCAAT/enhancer-binding protein alpha [C/ebpα] mRNA expression, adiponectin secretion, and intracellular lipid content), and glucose uptake (via a 2-deoxy-D-glucose [2-DG] assay) were evaluated. In both stages of adipocytes, H2O2 exposure significantly increased ROS levels and decreased SOD activity, and elevated extracellular IL-6, MCP-1, and TNF-α concentrations. These alterations were significantly attenuated by BOT co-treatment. Furthermore, BOT prevented the H2O2-induced downregulation of Pparγ and C/ebpα mRNA expression, thereby restoring adiponectin secretion and intracellular lipid content. Crucially, the marked impairment of 2-DG uptake caused by H2O2-mediated metabolic stress was significantly reversed by BOT co-treatment. These findings suggest that BOT exerts multi-targeted protective effects in 3T3-L1 adipocytes by mitigating oxidative stress, suppressing inflammation, and preserving adipocyte differentiation and function, thereby restoring impaired glucose uptake. Our study provides new insights into the therapeutic potential of BOT against insulin resistance and associated metabolic disorders.

11 April 2026 in Biology
Verified
Journal Article
Open access
PDF file
JLJingya Lu
Jingya Lu
AHAiling Hu
Ailing Hu
YLYunhai Lin
Yunhai Lin
YLYi Luo
Yi Luo
WYWenshu Yuan
Wenshu Yuan
HKHiroyuki Kobayashi
Hiroyuki Kobayashi
Shoseiryuto (SST) is a Kampo medicine widely used to treat respiratory diseases. We previously showed that SST attenuates lipopolysaccharide (LPS)-induced tight junction (TJ) barrier disruption in human bronchial epithelial (16HBE) cells. However, the underlying mechanisms remain unclear. This study aimed to clarify the mechanisms underlying the protective effects of SST. SST attenuated inflammatory responses (increased IL-6 protein and mRNA levels) and TJ disruption (decreased transepithelial electrical resistance, increased sodium fluorescein permeability, and decreased occludin mRNA and protein expression) induced by LPS, hydrogen peroxide (H2O2), tumor necrosis factor-α (TNF-α), and polyinosinic–polycytidylic acid (Poly I:C). Further analyses using the Poly I:C model confirmed that the effects of SST were comparable to those of the nuclear factor κB (NF-κB) inhibitors SC-514 and BAY11-7085. SST reduced the activation of NF-κB signaling (increased phosphorylation of NF-κB and IκB), similar to BAY11-7085. SST components, isoliquiritigenin (ILQG) and glycyrrhizin (GL), also attenuated inflammation, barrier dysfunction, and NF-κB signaling activity. These findings suggest that (1) activation of the NF-κB signaling pathway might be associated with both inflammatory responses and TJ barrier disruption; (2) SST could reduce these effects, potentially through modulation of NF-κB signaling; and (3) ILQG and GL may contribute, in part, to these activities. Overall, this study provides the first evidence suggesting that SST may exert anti-inflammatory and epithelial barrier-protective effects, possibly via the suppression of the NF-κB signaling pathway.